American Vietnamese Biotech Inc
American Vietnamese Biotech Inc operates in Pharmaceuticals.
Market Cap & Net Worth: American Vietnamese Biotech Inc (AMV)
American Vietnamese Biotech Inc (VN:AMV) has a market capitalization of $623.74 (₫15.85 Million) as of March 18, 2026. Listed on the VN stock exchange, this Vietnam-based company holds position #48671 globally and #584 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying American Vietnamese Biotech Inc's stock price ₫1600.00 by its total outstanding shares 9905 (9.90K).
American Vietnamese Biotech Inc Market Cap History: 2015 to 2025
American Vietnamese Biotech Inc's market capitalization history from 2015 to 2025. Data shows change from $1.33K to $623.74 (-10.55% CAGR).
Index Memberships
American Vietnamese Biotech Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
HNX
HNXI
|
$1.88 Million | 0.03% | #226 of 302 |
|
HNX Large Cap
HNXLC
|
$437.86K | 0.14% | #44 of 49 |
Weight: American Vietnamese Biotech Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
American Vietnamese Biotech Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how American Vietnamese Biotech Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of AMV by Market Capitalization
Companies near American Vietnamese Biotech Inc in the global market cap rankings as of March 18, 2026.
Key companies related to American Vietnamese Biotech Inc by market ranking:
- Sam Chun Dang Pharm. Co. Ltd (KQ:000250): Ranked #3465 globally with a market cap of $3.69 Billion USD ( ₩5.41 Trillion KRW).
- Mezzion Pharma Co.Ltd (KQ:140410): Ranked #6393 globally with a market cap of $1.27 Billion USD ( ₩1.86 Trillion KRW).
- ST Pharm Co.Ltd (KQ:237690): Ranked #7113 globally with a market cap of $1.05 Billion USD ( ₩1.54 Trillion KRW).
- Oscotec Inc (KQ:039200): Ranked #7795 globally with a market cap of $890.75 Million USD ( ₩1.30 Trillion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #3465 | Sam Chun Dang Pharm. Co. Ltd | KQ:000250 | $3.69 Billion | ₩739000.00 |
| #6393 | Mezzion Pharma Co.Ltd | KQ:140410 | $1.27 Billion | ₩89200.00 |
| #7113 | ST Pharm Co.Ltd | KQ:237690 | $1.05 Billion | ₩153400.00 |
| #7795 | Oscotec Inc | KQ:039200 | $890.75 Million | ₩54900.00 |
American Vietnamese Biotech Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, American Vietnamese Biotech Inc's market cap moved from $1.33K to $ 623.74, with a yearly change of -10.55%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | ₫623.74 | +6.67% |
| 2024 | ₫584.76 | -61.54% |
| 2023 | ₫1.52K | +18.18% |
| 2022 | ₫1.29K | -77.08% |
| 2021 | ₫5.61K | -32.08% |
| 2020 | ₫8.26K | -13.47% |
| 2019 | ₫9.55K | -35.53% |
| 2018 | ₫14.81K | +107.65% |
| 2017 | ₫7.13K | +101.10% |
| 2016 | ₫3.55K | +167.65% |
| 2015 | ₫1.33K | -- |
End of Day Market Cap According to Different Sources
On Jan 23rd, 2026 the market cap of American Vietnamese Biotech Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $623.74 USD |
| MoneyControl | $623.74 USD |
| MarketWatch | $623.74 USD |
| marketcap.company | $623.74 USD |
| Reuters | $623.74 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.